Current studies have found the likely tumorigenic roles of PRKACB in diverse malignant tumors, including gastrointestinal cancer (gastric, colon and pancreatic tumors) and others (breast, ovary, leukemia and brain tumors) [107–109]. The gene discussed is PRKACB; the disease is pancreatic neoplasm.